{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:31:08Z","timestamp":1766827868497,"version":"3.48.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005565","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"crossref","award":["Research Chair on Pandemic Preparedness"],"award-info":[{"award-number":["Research Chair on Pandemic Preparedness"]}],"id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G086623N"],"award-info":[{"award-number":["G086623N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Care Manag Sci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10729-025-09726-6","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:59:11Z","timestamp":1761044351000},"page":"583-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding modeling boundaries to design more resilient vaccine supply networks"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5238","authenticated-orcid":false,"given":"Donovan","family":"Guttieres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-2069","authenticated-orcid":false,"given":"Carla","family":"Van Riet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-7376","authenticated-orcid":false,"given":"Nico","family":"Vandaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4726-1729","authenticated-orcid":false,"given":"Catherine","family":"Decouttere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"9726_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","volume":"31","author":"S Ozawa","year":"2012","unstructured":"Ozawa S, Mirelman A, Stack ML et al (2012) Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review. Vaccine 31:96\u2013108. https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.103","journal-title":"Vaccine"},{"key":"9726_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1377\/hlthaff.2020.00103","volume":"39","author":"SY Sim","year":"2020","unstructured":"Sim SY, Watts E, Constenla D et al (2020) Return on investment from immunization against 10 pathogens in 94 low-and middle-income countries, 2011\u201330. Health Aff 39:1343\u20131353. https:\/\/doi.org\/10.1377\/hlthaff.2020.00103","journal-title":"Health Aff"},{"key":"9726_CR3","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","volume":"403","author":"AJ Shattock","year":"2024","unstructured":"Shattock AJ, Johnson HC, Sim SY et al (2024) Contribution of vaccination to improved survival and health: modelling 50 years of the expanded programme on immunization. Lancet 403:2307\u20132316. https:\/\/doi.org\/10.1016\/S0140-6736(24)00850-X","journal-title":"Lancet"},{"key":"9726_CR4","doi-asserted-by":"publisher","unstructured":"Wolf J, Bruno S, Eichberg M et al (2020) Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens. NPJ Vaccines 5:51. https:\/\/doi.org\/10.1038\/s41541-020-0204-7","DOI":"10.1038\/s41541-020-0204-7"},{"key":"9726_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","volume":"27","author":"JL Excler","year":"2021","unstructured":"Excler JL, Saville M, Berkley S, Kim JH (2021) Vaccine development for emerging infectious diseases. Nat Med 27:591\u2013600","journal-title":"Nat Med"},{"key":"9726_CR6","doi-asserted-by":"publisher","unstructured":"Pilkington V, Keestra SM, Hill A (2022) Global COVID-19 vaccine inequity: failures in the first year of distribution and potential solutions for the future. Front Public Health 10. https:\/\/doi.org\/10.3389\/fpubh.2022.821117","DOI":"10.3389\/fpubh.2022.821117"},{"key":"9726_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/20476965.2021.1992300","volume":"12","author":"C Decouttere","year":"2023","unstructured":"Decouttere C, Vandaele N, De Boeck K, Banzimana S (2023) A systems-Based framework for immunisation system design: six loops, three flows, two paradigms. Health Syst 12:36\u201351. https:\/\/doi.org\/10.1080\/20476965.2021.1992300","journal-title":"Health Syst"},{"key":"9726_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1108\/JHLSCM-05-2023-133","volume":"13","author":"N Vandaele","year":"2023","unstructured":"Vandaele N, Decouttere C (2023) Guest editorial: vaccine supply in perspective: from end-to-end supply chains to full-fledged immunization systems. J Humanitarian Logistics Supply Chain Manage 13:109\u2013110","journal-title":"J Humanitarian Logistics Supply Chain Manage"},{"key":"9726_CR9","unstructured":"Michael Porter (1985) Competitive advantage creating and sustaining superior performance. Free, NY"},{"key":"9726_CR10","doi-asserted-by":"crossref","unstructured":"Choi TY, Dooley KJ, Rungtusanatham M (2001) Supply networks and complex adaptive systems. control versus emergence","DOI":"10.1016\/S0272-6963(00)00068-1"},{"key":"9726_CR11","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1080\/00207540500142274","volume":"43","author":"A Surana","year":"2005","unstructured":"Surana A, Kumara S, Greaves M, Raghavan UN (2005) Supply-chain networks: A complex adaptive systems perspective. Int J Prod Res 43:4235\u20134265. https:\/\/doi.org\/10.1080\/00207540500142274","journal-title":"Int J Prod Res"},{"key":"9726_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1590\/1807-7692bar2014130002","volume":"11","author":"JJ Marchi","year":"2014","unstructured":"Marchi JJ, Erdmann RH, Rodriguez CMT (2014) Understanding supply networks from complex adaptive systems. BAR - Brazilian Adm Rev 11:441\u2013454. https:\/\/doi.org\/10.1590\/1807-7692bar2014130002","journal-title":"BAR - Brazilian Adm Rev"},{"key":"9726_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1108\/ejms-04-2021-0030","volume":"27","author":"M Abbasi","year":"2022","unstructured":"Abbasi M, Varga L (2022) Steering supply chains from a complex systems perspective. Eur J Manage Stud 27:5\u201338. https:\/\/doi.org\/10.1108\/ejms-04-2021-0030","journal-title":"Eur J Manage Stud"},{"key":"9726_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jom.2014.03.003","volume":"32","author":"Rv Ramasesh","year":"2014","unstructured":"Ramasesh Rv, Browning TR (2014) A conceptual framework for tackling knowable unknown unknowns in project management. J Oper Manag 32:190\u2013204. https:\/\/doi.org\/10.1016\/j.jom.2014.03.003","journal-title":"J Oper Manag"},{"key":"9726_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1108\/09600030810861198","volume":"38","author":"C Wycisk","year":"2008","unstructured":"Wycisk C, McKelvey B, H\u00fclsmann M (2008) Smart parts supply networks as complex adaptive systems: analysis and implications. Int J Phys Distribution Logistics Manage 38:108\u2013125. https:\/\/doi.org\/10.1108\/09600030810861198","journal-title":"Int J Phys Distribution Logistics Manage"},{"key":"9726_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/jscm.12248","volume":"57","author":"A Wieland","year":"2021","unstructured":"Wieland A (2021) Dancing the supply chain: toward transformative supply chain management. J Supply Chain Manage 57:58\u201373. https:\/\/doi.org\/10.1111\/jscm.12248","journal-title":"J Supply Chain Manage"},{"key":"9726_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1108\/01443570010321667","volume":"20","author":"R Lamming","year":"2000","unstructured":"Lamming R, Johnsen T, Zheng J, Harland C (2000) Classification of supply networks an initial classification of supply networks. International Journal of Operations and Production Management 20:675\u2013691. https:\/\/doi.org\/10.1108\/01443570010321667","journal-title":"International Journal of Operations and Production Management"},{"key":"9726_CR18","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","volume":"35","author":"S Plotkin","year":"2017","unstructured":"Plotkin S, Robinson JM, Cunningham G et al (2017) The complexity and cost of vaccine manufacturing \u2013 An overview. Vaccine 35:4064\u20134071","journal-title":"Vaccine"},{"key":"9726_CR19","unstructured":"World Trade Organization (2020) Developing and delivering COVID-19 vaccines around the world: An information note about issues with trade impact"},{"key":"9726_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejor.2018.01.015","volume":"268","author":"LE Duijzer","year":"2018","unstructured":"Duijzer LE, van Jaarsveld W, Dekker R (2018) Literature review: the vaccine supply chain. Eur J Oper Res 268:174\u2013192. https:\/\/doi.org\/10.1016\/j.ejor.2018.01.015","journal-title":"Eur J Oper Res"},{"key":"9726_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.puhe.2021.05.003","volume":"196","author":"MP Kelly","year":"2021","unstructured":"Kelly MP (2021) The relation between the social and the biological and COVID-19. Public Health 196:18\u201323. https:\/\/doi.org\/10.1016\/j.puhe.2021.05.003","journal-title":"Public Health"},{"key":"9726_CR22","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.34172\/ijhpm.2021.55","volume":"11","author":"D Wernli","year":"2022","unstructured":"Wernli D, Tediosi F, Blanchet K et al (2022) A complexity lens on the COVID-19 pandemic. Int J Health Policy Manag 11:2769\u20132772. https:\/\/doi.org\/10.34172\/ijhpm.2021.55","journal-title":"Int J Health Policy Manag"},{"key":"9726_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1403494820970767","volume":"49","author":"PM Schiefloe","year":"2021","unstructured":"Schiefloe PM (2021) The Corona crisis: a wicked problem. Scand J Public Health 49:5\u20138","journal-title":"Scand J Public Health"},{"key":"9726_CR24","doi-asserted-by":"publisher","unstructured":"Hadjisotiriou S, Marchau V, Walker W, Rikkert MO (2023) Decision making under deep uncertainty for pandemic policy planning. Health Policy (New York) 133. https:\/\/doi.org\/10.1016\/j.healthpol.2023.104831","DOI":"10.1016\/j.healthpol.2023.104831"},{"key":"9726_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1108\/SCM-05-2019-0184","volume":"26","author":"EV Yaroson","year":"2021","unstructured":"Yaroson EV, Breen L, Hou J, Sowter J (2021) Advancing the Understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory. Supply Chain Manage 26:323\u2013340. https:\/\/doi.org\/10.1108\/SCM-05-2019-0184","journal-title":"Supply Chain Manage"},{"key":"9726_CR26","doi-asserted-by":"publisher","unstructured":"Guttieres D, Van Riet C, Vandaele N, Decouttere C (2025) Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera. Vaccine 52. https:\/\/doi.org\/10.1016\/j.vaccine.2025.126889","DOI":"10.1016\/j.vaccine.2025.126889"},{"key":"9726_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.12688\/f1000research.126201.1","volume":"11","author":"J Borghi","year":"2022","unstructured":"Borghi J, Ismail S, Hollway J et al (2022) Viewing the global health system as a complex adaptive system - implications for research and practice. F1000Res 11:1147. https:\/\/doi.org\/10.12688\/f1000research.126201.1","journal-title":"F1000Res"},{"key":"9726_CR28","doi-asserted-by":"publisher","first-page":"105106","DOI":"10.1016\/j.worlddev.2020.105106","volume":"136","author":"F Angeli","year":"2020","unstructured":"Angeli F, Montefusco A (2020) Sensemaking and learning during the Covid-19 pandemic: A complex adaptive systems perspective on policy decision-making. World Dev 136:105106. https:\/\/doi.org\/10.1016\/j.worlddev.2020.105106","journal-title":"World Dev"},{"key":"9726_CR29","doi-asserted-by":"publisher","unstructured":"Talukder B, Schubert JE, Tofighi M et al (2024) Complex adaptive systems-based framework for modeling the health impacts of climate change. J Clim Change Health 15. https:\/\/doi.org\/10.1016\/j.joclim.2023.100292","DOI":"10.1016\/j.joclim.2023.100292"},{"key":"9726_CR30","doi-asserted-by":"crossref","unstructured":"Bown CP, Bollyky TJ (2021) Working Paper: How COVID-19 vaccine supply chains emerged in the midst of a pandemic. Washington D.C","DOI":"10.2139\/ssrn.3902082"},{"key":"9726_CR31","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1016\/j.vaccine.2023.05.027","volume":"41","author":"JJ Feddema","year":"2023","unstructured":"Feddema JJ, Fernald KDS, Schikan HGCP, van de Burgwal LHM (2023) Upscaling vaccine manufacturing capacity - key bottlenecks and lessons learned. Vaccine 41:4359\u20134368. https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.027","journal-title":"Vaccine"},{"key":"9726_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.vaccine.2023.12.031","volume":"42","author":"ML King","year":"2024","unstructured":"King ML (2024) How manufacturing won or lost the COVID-19 vaccine race. Vaccine 42:1004\u20131012","journal-title":"Vaccine"},{"key":"9726_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/oxrep\/grac036","volume":"38","author":"SD Kominers","year":"2022","unstructured":"Kominers SD, Tabarrok A (2022) Vaccines and the Covid-19 pandemic: lessons from failure and success. Oxf Rev Econ Policy 38:719\u2013741. https:\/\/doi.org\/10.1093\/oxrep\/grac036","journal-title":"Oxf Rev Econ Policy"},{"key":"9726_CR34","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/14760584.2024.2395546","volume":"23","author":"S Agampodi","year":"2024","unstructured":"Agampodi S, Mogeni OD, Chandler R et al (2024) Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution. Expert Rev Vaccines 23:761\u2013772. https:\/\/doi.org\/10.1080\/14760584.2024.2395546","journal-title":"Expert Rev Vaccines"},{"key":"9726_CR35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/su5030955","volume":"5","author":"WE Walker","year":"2013","unstructured":"Walker WE, Haasnoot M, Kwakkel JH (2013) Adapt or perish: A review of planning approaches for adaptation under deep uncertainty. Sustain (Switzerland) 5:955\u2013979. https:\/\/doi.org\/10.3390\/su5030955","journal-title":"Sustain (Switzerland)"},{"key":"9726_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/risks9010016","volume":"9","author":"A Gurtu","year":"2021","unstructured":"Gurtu A, Johny J (2021) Supply chain risk management: literature review. Risks 9:1\u201316","journal-title":"Risks"},{"key":"9726_CR37","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.vaccine.2022.02.036","volume":"40","author":"BD Trump","year":"2022","unstructured":"Trump BD, Golan MS, Keisler JM et al (2022) Vaccine supply chain: Resilience-by-design and resilience-by-intervention. Vaccine 40:1695\u20131698","journal-title":"Vaccine"},{"key":"9726_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1108\/09600030210437951","volume":"32","author":"JGAJ Van Der Vorst","year":"2002","unstructured":"Van Der Vorst JGAJ, Beulens AJM (2002) Identifying sources of uncertainty to generate supply chain redesign strategies. Int J Phys Distribution Logistics Manage 32:409\u2013430. https:\/\/doi.org\/10.1108\/09600030210437951","journal-title":"Int J Phys Distribution Logistics Manage"},{"key":"9726_CR39","unstructured":"Chopra S, Sodhi MS (2004) Managing risk to avoid Supply-Chain breakdown. MIT Sloan Manag Rev Fall"},{"key":"9726_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cherd.2016.02.015","volume":"109","author":"S Lemmens","year":"2016","unstructured":"Lemmens S, Decouttere C, Vandaele N, Bernuzzi M (2016) A review of integrated supply chain network design models: key issues for vaccine supply chains. Chem Eng Res Des 109:366\u2013384","journal-title":"Chem Eng Res Des"},{"key":"9726_CR41","doi-asserted-by":"crossref","unstructured":"Ekambaram A, Shamir A (2015) Facility design for vaccine manufacturing: Regulatory, business, and technical considerations and a risk-based design approach. In: Wen E, Ellis R, Pujar N (eds) Vaccine Development and Manufacturing. Wiley Series in Biotechnology and Bioengineering, pp 393\u2013412","DOI":"10.1002\/9781118870914.ch14"},{"key":"9726_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1570-7946(01)80138-3","volume":"9","author":"G Gatica","year":"2001","unstructured":"Gatica G, Shah N, Papageorgiou LG (2001) Capacity planning under clinical trials uncertainty for the pharmaceutical industry. Comput Aided Chem Eng 9:865\u2013870","journal-title":"Comput Aided Chem Eng"},{"key":"9726_CR43","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.coche.2023.100998","volume":"43","author":"E Ramin","year":"2024","unstructured":"Ramin E, Cardillo AG, Liebers R et al (2024) Accelerating vaccine manufacturing development through model-based approaches: current advances and future opportunities. Curr Opin Chem Eng 43:100998. https:\/\/doi.org\/10.1016\/j.coche.2023.100998","journal-title":"Curr Opin Chem Eng"},{"key":"9726_CR44","doi-asserted-by":"publisher","unstructured":"Kis Z, Kontoravdi C, Shattock R, Shah N (2020) Resources, production scales and time required for producing RNA vaccines for the global pandemic demand. Vaccines (Basel) https:\/\/doi.org\/10.3390\/vaccines","DOI":"10.3390\/vaccines"},{"key":"9726_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-022-00447-3","volume":"7","author":"Z Kis","year":"2022","unstructured":"Kis Z, Tak K, Ibrahim D et al (2022) Pandemic-response adenoviral vector and RNA vaccine manufacturing. NPJ Vaccines 7:29. https:\/\/doi.org\/10.1038\/s41541-022-00447-3","journal-title":"NPJ Vaccines"},{"key":"9726_CR46","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1016\/j.vaccine.2014.04.090","volume":"32","author":"ST Brown","year":"2014","unstructured":"Brown ST, Schreiber B, Cakouros BE et al (2014) The benefits of redesigning benin\u2019s vaccine supply chain. Vaccine 32:4097\u20134103. https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.090","journal-title":"Vaccine"},{"key":"9726_CR47","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1016\/j.vaccine.2016.08.036","volume":"34","author":"BY Lee","year":"2016","unstructured":"Lee BY, Haidari LA, Prosser W et al (2016) Re-designing the Mozambique vaccine supply chain to improve access to vaccines. Vaccine 34:4998\u20135004. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.036","journal-title":"Vaccine"},{"key":"9726_CR48","doi-asserted-by":"publisher","first-page":"986776","DOI":"10.3389\/fpubh.2022.986776","volume":"10","author":"A Tur-Sinai","year":"2022","unstructured":"Tur-Sinai A, Valera L, Kalanj K, C, Al\u00f3s-Ferrer (2022) Ethical allocation of scarce vaccine doses: The Priority-Equality protocol. Frontiers in Public Health 10:986776. https:\/\/doi.org\/10.3389\/fpubh.2022.986776","journal-title":"Frontiers in Public Health"},{"key":"9726_CR49","doi-asserted-by":"publisher","unstructured":"Dogra P, Schiavone C, Wang Z et al (2023) A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection. JCI Insight. https:\/\/doi.org\/10.1172\/jci","DOI":"10.1172\/jci"},{"key":"9726_CR50","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41591-022-01736-z","volume":"28","author":"Z Du","year":"2022","unstructured":"Du Z, Wang L, Pandey A et al (2022) Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nat Med 28:934\u2013938. https:\/\/doi.org\/10.1038\/s41591-022-01736-z","journal-title":"Nat Med"},{"key":"9726_CR51","doi-asserted-by":"publisher","first-page":"20425","DOI":"10.1038\/s41598-024-71322-5","volume":"14","author":"H Kim","year":"2024","unstructured":"Kim H, Cha H, Cheong T (2024) Analyzing economic effect on mRNA vaccine inventory management with redistribution policy. Sci Rep 14:20425. https:\/\/doi.org\/10.1038\/s41598-024-71322-5","journal-title":"Sci Rep"},{"key":"9726_CR52","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","volume":"396","author":"A de Figueiredo","year":"2020","unstructured":"de Figueiredo A, Simas C, Karafillakis E et al (2020) Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective Temporal modelling study. Lancet 396:898\u2013908. https:\/\/doi.org\/10.1016\/S0140-6736(20)31558-0","journal-title":"Lancet"},{"key":"9726_CR53","doi-asserted-by":"publisher","first-page":"20377","DOI":"10.1038\/s41598-022-24967-z","volume":"12","author":"Z LaJoie","year":"2022","unstructured":"LaJoie Z, Usherwood T, Sampath S, Srivastava V (2022) A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior. Sci Rep 12:20377. https:\/\/doi.org\/10.1038\/s41598-022-24967-z","journal-title":"Sci Rep"},{"key":"9726_CR54","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/nav.22181","volume":"71","author":"S Dey","year":"2024","unstructured":"Dey S, Kurbanzade AK, Gel ES et al (2024) Optimization modeling for pandemic vaccine supply chain management: A review and future research opportunities. Nav Res Logist 71:976\u20131016. https:\/\/doi.org\/10.1002\/nav.22181","journal-title":"Nav Res Logist"},{"key":"9726_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/vaccines12010024","volume":"12","author":"D Guttieres","year":"2024","unstructured":"Guttieres D, Diepvens C, Decouttere C, Vandaele N (2024) Modeling supply and demand dynamics of vaccines against Epidemic-Prone pathogens: case study of Ebola virus disease. Vaccines (Basel) 12:24. https:\/\/doi.org\/10.3390\/vaccines12010024","journal-title":"Vaccines (Basel)"},{"key":"9726_CR56","first-page":"74","volume":"4","author":"E Settanni","year":"2017","unstructured":"Settanni E, Harrington TS, Srai JS (2017) Pharmaceutical supply chain models: A synthesis from a systems view of operations research. Oper Res Perspect 4:74\u201395","journal-title":"Oper Res Perspect"},{"key":"9726_CR57","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1016\/j.vaccine.2022.05.054","volume":"40","author":"M Rodes-Sanchez","year":"2022","unstructured":"Rodes-Sanchez M, Spencer J, Tantri A et al (2022) Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking. Vaccine 40:3919\u20133922","journal-title":"Vaccine"},{"key":"9726_CR58","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1016\/j.vaccine.2022.07.032","volume":"42","author":"T Cernuschi","year":"2024","unstructured":"Cernuschi T, Malvolti S, Hall S et al (2024) The quest for more effective vaccine markets \u2013 Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic. Vaccine 42:S64\u2013S72. https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.032","journal-title":"Vaccine"},{"key":"9726_CR59","doi-asserted-by":"publisher","unstructured":"Chaouni Benabdellah A, Bouhaddou I, Benghabrit A (2018) Supply chain challenges with complex adaptive system perspective. In: Rocha \u00c1, Adeli H, Reis LP, Costanzo S (eds). Advances in Intelligent Systems and Computing. Springer, pp 1081\u20131093.\u00a0https:\/\/doi.org\/10.1007\/978-3-319-77703-0_105","DOI":"10.1007\/978-3-319-77703-0_105"},{"key":"9726_CR60","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s10669-020-09777-w","volume":"40","author":"MS Golan","year":"2020","unstructured":"Golan MS, Jernegan LH, Linkov I (2020) Trends and applications of resilience analytics in supply chain modeling: systematic literature review in the context of the COVID-19 pandemic. Environ Syst Decis 40:222\u2013243","journal-title":"Environ Syst Decis"},{"key":"9726_CR61","unstructured":"Hallegatte S, Shah A, Lempert R et al (2012) Investment Decision Making Under Deep Uncertainty Application to Climate Change. World Bank Policy Research Working Paper No. 6193."},{"key":"9726_CR62","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/sres.2225","volume":"32","author":"JH Kwakkel","year":"2015","unstructured":"Kwakkel JH, Pruyt E (2015) Using system dynamics for grand challenges: the ESDMA approach. Syst Res Behav Sci 32:358\u2013375. https:\/\/doi.org\/10.1002\/sres.2225","journal-title":"Syst Res Behav Sci"},{"key":"9726_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1287\/mnsc.1050.0472","volume":"52","author":"RJ Lempert","year":"2006","unstructured":"Lempert RJ, Groves DG, Popper SW, Bankes SC (2006) A general, analytic method for generating robust strategies and narrative scenarios. Manage Sci 52:514\u2013528. https:\/\/doi.org\/10.1287\/mnsc.1050.0472","journal-title":"Manage Sci"},{"key":"9726_CR64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.gloenvcha.2012.12.006","volume":"23","author":"M Haasnoot","year":"2013","unstructured":"Haasnoot M, Kwakkel JH, Walker WE, ter Maat J (2013) Dynamic adaptive policy pathways: A method for crafting robust decisions for a deeply uncertain world. Glob Environ Change 23:485\u2013498. https:\/\/doi.org\/10.1016\/j.gloenvcha.2012.12.006","journal-title":"Glob Environ Change"},{"key":"9726_CR65","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/wcc.64","volume":"1","author":"JCJ Kwadijk","year":"2010","unstructured":"Kwadijk JCJ, Haasnoot M, Mulder JPM et al (2010) Using adaptation tipping points to prepare for climate change and sea level rise: A case study in the Netherlands. Wiley Interdiscip Rev Clim Change 1:729\u2013740. https:\/\/doi.org\/10.1002\/wcc.64","journal-title":"Wiley Interdiscip Rev Clim Change"},{"key":"9726_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2307\/309","volume":"47","author":"N Repenning","year":"2002","unstructured":"Repenning N, Sterman J (2002) Capability traps and Self-Confirming attribution errors in the dynamics of process improvement. Adm Sci Q 47:265\u2013295. https:\/\/doi.org\/10.2307\/309","journal-title":"Adm Sci Q"},{"key":"9726_CR67","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1540-5915.2007.00170.x","volume":"38","author":"SD Pathak","year":"2007","unstructured":"Pathak SD, Day JM, Nair A et al (2007) Complexity and adaptivity in supply networks: Building supply network theory using a complex adaptive systems perspective. Decis Sci 38:547\u2013580. https:\/\/doi.org\/10.1111\/j.1540-5915.2007.00170.x","journal-title":"Decis Sci"},{"key":"9726_CR68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/sdr.442","volume":"27","author":"N Ghaffarzadegan","year":"2011","unstructured":"Ghaffarzadegan N, Lyneis J, Richardson GP (2011) How small system dynamics models can help the public policy process. Syst Dyn Rev 27:22\u201344. https:\/\/doi.org\/10.1002\/sdr.442","journal-title":"Syst Dyn Rev"},{"key":"9726_CR69","doi-asserted-by":"publisher","first-page":"204","DOI":"10.12688\/openreseurope.18440.1","volume":"4","author":"P Cairney","year":"2024","unstructured":"Cairney P, Toomey C (2024) Collaborative policymaking: a qualitative systematic review of advice for policymakers. Open Res Europe 4:204. https:\/\/doi.org\/10.12688\/openreseurope.18440.1","journal-title":"Open Res Europe"},{"key":"9726_CR70","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s10488-016-0754-1","volume":"43","author":"L Zimmerman","year":"2016","unstructured":"Zimmerman L, Lounsbury DW, Rosen CS et al (2016) Participatory system dynamics modeling: increasing stakeholder engagement and precision to improve implementation planning in systems. Adm Policy Mental Health Mental Health Serv Res 43:834\u2013849. https:\/\/doi.org\/10.1007\/s10488-016-0754-1","journal-title":"Adm Policy Mental Health Mental Health Serv Res"},{"key":"9726_CR71","doi-asserted-by":"publisher","unstructured":"Scrieciu \u015e, Varga L, Zimmermann N et al (2022) An Inquiry into Model Validity When Addressing Complex Sustainability Challenges. Complexity 1193891.\u00a0https:\/\/doi.org\/10.1155\/2022\/1193891","DOI":"10.1155\/2022\/1193891"},{"key":"9726_CR72","doi-asserted-by":"publisher","first-page":"100119","DOI":"10.1016\/j.jvacx.2021.100119","volume":"9","author":"S Jarrett","year":"2021","unstructured":"Jarrett S, Pagliusi S, Park R et al (2021) The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers. Vaccine X 9:100119. https:\/\/doi.org\/10.1016\/j.jvacx.2021.100119","journal-title":"Vaccine X"},{"key":"9726_CR73","doi-asserted-by":"publisher","unstructured":"Williams BA, Jones CH, Welch V, True JM (2023) Outlook of pandemic preparedness in a post-COVID-19 world. NPJ Vaccines 8:178. https:\/\/doi.org\/10.1038\/s41541-023-00773-0","DOI":"10.1038\/s41541-023-00773-0"},{"key":"9726_CR74","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/S0140-6736(22)00793-0","volume":"399","author":"VJ Dzau","year":"2022","unstructured":"Dzau VJ, Balatbat CA, Offodile AC (2022) Closing the global vaccine equity gap: equitably distributed manufacturing. Lancet 399:1924\u20131926","journal-title":"Lancet"},{"key":"9726_CR75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40273-024-01396-6","volume":"42","author":"F McElwee","year":"2024","unstructured":"McElwee F, Newall A (2024) The value of flexible vaccine manufacturing capacity: value drivers, Estimation methods, and approaches to value recognition in health technology assessment. PharmacoEconomics 42:187\u2013197. https:\/\/doi.org\/10.1007\/s40273-024-01396-6","journal-title":"PharmacoEconomics"},{"key":"9726_CR76","doi-asserted-by":"crossref","unstructured":"Agarwal R, Reed T (2022) Finance Vaccine Equity. Funding for day-zero of the next pandemic. World Bank Group Policy Research working paper; no. WPS 10067.","DOI":"10.1596\/1813-9450-10067"},{"key":"9726_CR77","doi-asserted-by":"publisher","first-page":"e1658","DOI":"10.1016\/s2214-109x(23)00328-5","volume":"11","author":"E Torreele","year":"2023","unstructured":"Torreele E, Wolfe D, Kazatchkine M et al (2023) From private incentives to public health need: rethinking research and development for pandemic preparedness. Lancet Glob Health 11:e1658\u2013e1666. https:\/\/doi.org\/10.1016\/s2214-109x(23)00328-5","journal-title":"Lancet Glob Health"}],"container-title":["Health Care Management Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-025-09726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10729-025-09726-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-025-09726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:27:11Z","timestamp":1766827631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10729-025-09726-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9726"],"URL":"https:\/\/doi.org\/10.1007\/s10729-025-09726-6","relation":{},"ISSN":["1386-9620","1572-9389"],"issn-type":[{"type":"print","value":"1386-9620"},{"type":"electronic","value":"1572-9389"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DG received PhD funding from Johnson & Johnson Innovative Medicine via a donation to the Research Chair on Pandemic Preparedness within the Access-To-Medicines Research Centre at KU Leuven. The funder of the study had no role in the study design, data collection, data analysis, data interpretation, writing, review, or decision to submit the manuscript. CVR, NV, and CD have no competing financial or other interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}